Key Decisions and Quantitative Figures

1. Financial Results Approval

The Board approved the following financial results for the quarter and half year ended September 30, 2026:

  • Standalone Un-audited Financial Results along with the Limited Review Report under Regulation 33.
  • Consolidated Un-audited Financial Results under Regulation 33.

2. Extension of Preferential Issue Proceeds Timeline

The Board approved the extension of the timeline for utilization of unutilized proceeds from the Preferential Issue by another 12 months, i.e., up to November 12, 2027.

  • Total Issue Proceeds: ₹103,11,94,333
  • Amount Utilized to Date: ₹79,61,94,333
  • Unutilized Amount as of disclosure: ₹23,50,00,000
  • Purpose of Unutilized Funds: "Investment in AIFs as 'Sponsor' in line with SEBI (Alternative Investment Funds) Regulations, 2012" where the company's Wholly Owned Subsidiary (WOS), Systematix Wealth & Asset Services Private Limited, acts as "Investment Manager".
  • SEBI approval for Registration of AIFs has been obtained.
  • The proposed deployment is dependent on identification of suitable contributors, investment opportunities, market conditions, and finalization of investment structures.
  • There is no change in the objects of the issue; the approval pertains solely to the timeline extension.
  • Unutilized proceeds are maintained in compliance with the Companies Act, 2013, and SEBI (ICDR) Regulations, 2018.

Standalone Financial Results (₹ in Lakhs)

Income Statement Highlights (Quarter Ended Sept 30, 2026)

  • Total Income: ₹3996.59
  • Revenue from Operations: ₹269.12 (Interest Income: ₹2,529.04, Sale of Services: ₹30.41, Net gain on Fair value changes: ₹1.86, Impairment on financial instruments: ₹96.17)
  • Other Income: ₹80.25
  • Total Expenses: ₹1087.18
  • Profit Before Tax: ₹2425.68
  • Tax Expense: ₹626.59
  • Net Profit for the period: ₹1799.09
  • Earnings Per Share (Basic & Diluted): ₹1.32

Balance Sheet Highlights (As at Sept 30, 2026)

  • Total Assets: ₹29,733.18
  • Financial Assets: ₹27,656.33 (Cash & Cash Equivalents: ₹3.79, Bank Balances: ₹7,086.52, Investments: ₹18,571.02)
  • Total Liabilities: ₹4,537.03 (Financial Liabilities)
  • Equity: ₹24,884.48 (Share Capital: ₹1,372.50, Other Equity: ₹23,511.99)

Consolidated Financial Results (₹ in Lakhs)

Income Statement Highlights (Quarter Ended Sept 30, 2026)

  • Total Income: ₹5,879.55
  • Revenue from Operations: ₹576.73 (Interest income: ₹2,356.40, Fees: ₹2,602.32, Sale of services: ₹191.68, Sale of shares: ₹54.18, Net gain on fair value changes: ₹98.23)
  • Profit Before Tax: ₹1,718.78
  • Tax Expense: ₹405.54
  • Net Profit for the period (attributable to owners): ₹1,313.25
  • Earnings Per Share (Basic & Diluted): ₹0.96

Balance Sheet Highlights (As at Sept 30, 2026)

  • Total Assets: ₹46,325.37
  • Financial Assets: ₹41,974.21 (Cash & Cash Equivalents: ₹1,960.65, Bank Balances: ₹23,554.35, Investments: ₹4,106.04)
  • Total Liabilities: ₹13,304.63 (Financial Liabilities)
  • Equity: ₹32,245.93 (Share Capital: ₹1,372.50, Other Equity: ₹30,874.54, Minority Interest: ₹(1.10))

Subsidiary and Investment Updates

  • The company invested ₹14.20 crore in its WOS, Systematix Wealth & Asset Services Private Limited, through a rights issue in Jul-Aug-Sep 2026.
  • As of September 30, 2026, the company has contributed ₹6.50 crore out of a commitment of ₹10 crore to the India SME Growth Fund Series 2 (AIF). The company is the Sponsor, and its WOS is the Investment Manager.
  • Divisha Alternative Investments LLP, a subsidiary, was struck off from the LLP Register on July 21, 2026, and ceased to be a subsidiary from that date.

Regulatory and Legal Matter

A note in the consolidated results refers to an ongoing matter with SEBI concerning Systematix Commodities Services Private Limited (SCSPL). SEBI had cancelled its certificate of registration in Dec 2023. SAT granted a stay in Jan 2024. The matter, after several orders, remains pending adjudication with the next hearing scheduled for January 21, 2027. The company states it is taking efforts to safeguard client interests and believes it can continue as a going concern.

ESOP Scheme

Under the "Systematix Employee Stock Option Scheme, 2025," 6,91,142 options were outstanding as of September 30, 2026. No options lapsed during the quarter.

Meeting Details

The Board meeting commenced at 5:45 PM and concluded at 6:30 PM on November 12, 2026.

Auditor's Review

The limited review of both standalone and consolidated results was performed by Shah & Taparia Chartered Accountants, who issued an unmodified report.

#Tags: #SystematixCorporateServices #Q2Results #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Neutral